Related Experiment Video

Updated: Jun 21, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Ribosome-component immune modulation of respiratory tract infections in children

Alessandro Fiocchi1, Luigi Terracciano, Alberto Martelli

  • 1Department of Child and Maternal Medicine, Fatebenefratelli/Melloni University Hospital, Milan, Italy.

Allergy and Asthma Proceedings
|August 15, 2009
PubMed

Insights

Recurrent respiratory infections (RRIs) affect many young children. A ribosome-component immune modulator (RCIM) effectively prevents and reduces the severity of these infections with minimal risk.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Recurrent respiratory infections (RRIs) are common in children, affecting over 25% of infants and 18% of toddlers.
  • While often self-limiting, RRIs can lead to complications like otitis media and sinusitis.
  • Immune modulators can stimulate a more effective immune response to combat infections.

Purpose of the Study:

  • To review available data on immune modulators for preventing RRIs in children.
  • To describe a specific ribosome-component immune modulator (RCIM) designed for pediatric use.
  • To evaluate the efficacy and safety of RCIM in managing RRIs.

Main Methods:

  • A narrative literature review was conducted, focusing on clinical trials.
  • Data from double-blind, placebo-controlled studies were analyzed.
  • The review assessed the impact of RCIM on infection rates, severity, and related healthcare utilization.

Main Results:

  • RCIM demonstrated effectiveness in preventing recurrent bronchopulmonary and ear-nose-throat infections.
  • Significant reductions were observed in the number, severity, and duration of infectious episodes.
  • The use of RCIM decreased antibiotic courses, concomitant medications, and missed school/work days.

Conclusions:

  • RCIM is a clinically efficacious therapeutic approach for managing RRIs in children.
  • RCIM offers a safe treatment option with a minimal risk of adverse events.
  • This immune modulator represents a consistent and effective strategy for preventing and alleviating RRIs.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Translational Regulation01:29

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...